Results 21 to 30 of about 3,921,277 (285)

Advanced flow cell design for in vitro release testing of mucoadhesive buccal films

open access: yesActa Pharmaceutica, 2020
Films for buccal application are a slowly emerging new platform for drug delivery. There remains a lack of analytical techniques for the determination of in vitro active pharmaceutical ingredient release. The aim here was to develop an alternative method
Grilc Blaž   +2 more
doaj   +1 more source

Determination of active pharmaceutical ingredient – chloropyramine in dragées [PDF]

open access: yes, 2015
Chloropyramine is a first generation antihistamine drug approved in some Eastern European countries for the treatment of allergic conjunctivitis, allergic rhinitis, bronchial asthma, and other allergic conditions. Chloropyramine is known as a competitive
Gjorgjeska, Biljana   +2 more
core   +3 more sources

Binary Mixtures of Some Active Pharmaceutical Ingredients with Fatty Alcohols—The Criteria of Successful Eutectic Formation and Dissolution Improvement

open access: yesPharmaceutics, 2020
Pharmaceutical eutectics are solid mixtures, where the crystals of active pharmaceutical ingredients (APIs) are finely divided in the phase-separated microstructures.
Songhee Jin   +3 more
doaj   +1 more source

5-(7-Methanesulfonyl-2-morpholin-4-yl-6,7-dihydro-5H-pyrrolo[2,3-d]pyrimidin-4-yl)-pyrimidin-2-ylamine mesylate

open access: yesIUCrData, 2017
In the title compound, C15H20N7O3S+·CH3O3S− (CH5132799 mesylate), two molecular entities form a salt with proton transfer from methanesulfonic acid to the aminopyrimidine moiety of CH5132799.
Masahide Aoki   +5 more
doaj   +1 more source

Eutectic Formation of Naproxen with Some Dicarboxylic Acids

open access: yesPharmaceutics, 2021
Eutectic formation with additives is one of the established methods to improve the dissolution behaviors of active pharmaceutic ingredients (APIs). The improvement is mainly due to the increase in the surface area for dissolution, which originates from ...
Dahye Kim, Soeun Jang, Il Won Kim
doaj   +1 more source

Crystallization Behavior of Ceritinib: Characterization and Optimization Strategies

open access: yesChemEngineering, 2023
Because of the specific thermodynamic properties of active pharmaceutical ingredients, the process of crystallization often meets implementation challenges in the pharmaceutical industry.
Iva Zokić, Jasna Prlić Kardum
doaj   +1 more source

Computer-Aided Retrosynthesis for Greener and Optimal Total Synthesis of a Helicase-Primase Inhibitor Active Pharmaceutical Ingredient. [PDF]

open access: yesJACS Au
This study explores the application of computer-aided retrosynthesis (CAR) for developing greener and more efficient synthetic routes for the active pharmaceutical ingredient (API) IM-204, a helicase primase inhibitor with potential against Herpes ...
Teixeira RI   +3 more
europepmc   +3 more sources

Influence of pH, Temperature and Impurities on the Solubility of an Active Pharmaceutical Ingredient (API) [PDF]

open access: yes, 2010
Solubility, which defines the liquid /solid equilibrium, is a key parameter to control a crystallization process. This work is focused on the effects of pH, temperature and impurities on the aqueous solubility of an Active Pharmaceutical Ingredient (API).
Estime, Nicolas   +7 more
core   +1 more source

Method of the Metronidazole and Clotrimazole administration in the content of the emulsion basis

open access: yesZaporožskij Medicinskij Žurnal, 2013
Proved optimum method of administration of active pharmaceutical ingredients – metronidazole and clotrimazole – in the emulsion base of ointment as a suspension with vaseline oil.
V. V. Rudenko, S. V. Biryukova
doaj   +1 more source

Light-sensitive medicinal compounds – the actual review of studies and strategies in proceedings [PDF]

open access: yesFarmacja Polska, 2019
The main procedure for stability testing of Active Pharmaceutical Ingredients (API) and medicinal products is described in the guidelines of the International Council for the Harmonization of Technical Requirements for Human Drugs (ICH).
Marzena Jamrógiewicz   +2 more
doaj   +1 more source

Home - About - Disclaimer - Privacy